データなし
12 Health Care Stocks Moving In Friday's Pre-Market Session
BioAtla Prices Registered Direct Offering of 9.7 Million Shares for Expected Gross Proceeds of $9.2 Million
BioAtla Announces $9.2M Registered Direct Offering Of 9,679,158 Shares At $1.19/Share
Insiders Give Up US$66k As BioAtla Stock Drops To US$1.31
BioAtla Presented Data Characterizing Mutated KRAS Genotype And Clinical Outcomes In Patients With Advanced NSCLC Treated With Mecbotamab Vedotin, A CAB-AXL-ADC, At The IASLC 2024; 1-Year OS Was 58% For Patients With NSCLC Expressing MKRAS Versus 23%...
BioAtla Announces Upcoming Poster Presentation at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting